Celgene Corp (CELG)

CELG (NASDAQ:Drugs) EQUITY
$137.74
pos +0.00
+0.00%
Today's Range: 135.72 - 138.17 | CELG Avg Daily Volume: 3,970,200
Last Update: 07/21/17 - 4:00 PM EDT
Volume: 0
YTD Performance: 17.76%
Open: $0.00
Previous Close: $136.31
52 Week Range: $96.93 - $138.17
Oustanding Shares: 780,824,335
Market Cap: 106,434,165,104
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 13 14 13 15
Moderate Buy 0 0 0 0
Hold 3 2 3 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.38 1.25 1.38 1.24
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 51.24
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
51.24 51.20 30.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
10.58% 28.19% 60.25%
GROWTH 12 Mo 3 Yr CAGR
Revenue 21.30 0.70 0.20
Net Income 24.80 0.40 0.11
EPS 28.40 0.50 0.14
Earnings for CELG:
EBITDA 3.71B
Revenue 11.23B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $1.61 $1.70 $6.62 $8.21
Number of Analysts 7 7 8 4
High Estimate $1.68 $1.77 $6.79 $8.51
Low Estimate $1.53 $1.66 $6.49 $7.79
Prior Year $1.28 $1.39 $5.18 $6.62
Growth Rate (Year over Year) 25.89% 22.40% 27.80% 24.06%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Jim Cramer

 | Jul 20, 2017 | 3:57 PM EDT
Case in point: Home Depot and Lowe's.
RMPIA
By

Doug Kass

 | Jul 11, 2017 | 3:18 PM EDT
"If it is what you say I love it...." - Donald Trump Jr Risk Happens Fast -- and the reverberations of today's disclosures may …
RMPIA

updateCelgene Initiated with Buy Rating at Jefferies

Jul 11, 2017 | 8:57 AM EDT

Celgene stock coverage was initiated at Jefferies with a "Buy" rating and a $160 price target.

RMPIA
By

Bret Jensen

 | Jul 7, 2017 | 1:30 PM EDT
The two giants likely won't be home runs, but they remain stalwarts in the biotech space.
RMPIA
By

Bret Jensen

 | Jul 7, 2017 | 11:30 AM EDT
The two giants likely won't be home runs, but they remain stalwarts in the biotech space.
RMPIA

bearishCelgene Cut to Neutral at BTIG Research

Jun 30, 2017 | 9:05 AM EDT
Celgene was downgraded to "neutral" from "buy" at BTIG Research
RMPIA
By

Doug Kass

 | Jun 27, 2017 | 4:53 PM EDT
"I'd unravel every riddle for any individ'le, In trouble or in pain. With the thoughts I'd be thinkin' I could be another Lin …
RMPIA
By

Jim Cramer

 | Jun 23, 2017 | 6:37 AM EDT
It just isn't as useful or descriptive right now.
RMPIA
By

Bret Jensen

 | Jun 22, 2017 | 11:30 AM EDT
The sector decisively has pushed through upward resistance levels in place for many months.
RMPIA
By

Doug Kass

 | Jun 22, 2017 | 7:12 AM EDT
"For a day where the S&P was essentially flat, there was a lot going on beneath the surface.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.